請以 PICO 架構分析本文，並重點摘要 Primary Endpoints 的 HR 值與 P-value

Created using ChatSlide

Introducing the ROSELLA Phase 3 trial, this keynote delves into pivotal advancements in ovarian cancer research, focusing on overcoming challenges posed by platinum-resistant types. It emphasizes the role of GR signaling and the innovative use of relacorilant. Key discussion points include study methodology, highlighting patient criteria and treatment arms, alongside significant findings such as progression-free survival outcomes. The session concludes with an analysis of efficacy and...